Annual revenue:
$1.90B+$658.64M(+52.97%)Summary
- As of today (August 20, 2025), SRPT annual revenue is $1.90 billion, with the most recent change of +$658.64 million (+52.97%) on December 31, 2024.
- During the last 3 years, SRPT annual revenue has risen by +$1.20 billion (+170.98%).
- SRPT annual revenue is now at all-time high.
Performance
SRPT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$611.09M-$133.76M(-17.96%)Summary
- As of today (August 20, 2025), SRPT quarterly revenue is $611.09 million, with the most recent change of -$133.76 million (-17.96%) on June 30, 2025.
- Over the past year, SRPT quarterly revenue has increased by +$248.16 million (+68.38%).
- SRPT quarterly revenue is now -17.96% below its all-time high of $744.86 million, reached on March 31, 2025.
Performance
SRPT Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$2.48B+$248.16M(+11.11%)Summary
- As of today (August 20, 2025), SRPT TTM revenue is $2.48 billion, with the most recent change of +$248.16 million (+11.11%) on June 30, 2025.
- Over the past year, SRPT TTM revenue has increased by +$976.54 million (+64.89%).
- SRPT TTM revenue is now at all-time high.
Performance
SRPT TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
SRPT Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +53.0% | +68.4% | +64.9% |
| 3 y3 years | +171.0% | +161.7% | +197.1% |
| 5 y5 years | +399.4% | +344.9% | +451.2% |
SRPT Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +171.0% | -18.0% | +165.4% | at high | +197.1% |
| 5 y | 5-year | at high | +399.4% | -18.0% | +344.9% | at high | +451.2% |
| alltime | all time | at high | >+9999.0% | -18.0% | >+9999.0% | at high | >+9999.0% |
SRPT Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $611.09M(-18.0%) | $2.48B(+11.1%) |
| Mar 2025 | - | $744.86M(+13.1%) | $2.23B(+17.4%) |
| Dec 2024 | $1.90B(+53.0%) | $658.41M(+40.9%) | $1.90B(+15.9%) |
| Sep 2024 | - | $467.17M(+28.7%) | $1.64B(+9.0%) |
| Jun 2024 | - | $362.93M(-12.2%) | $1.50B(+7.2%) |
| Mar 2024 | - | $413.46M(+4.2%) | $1.40B(+12.9%) |
| Dec 2023 | $1.24B(+33.3%) | $396.78M(+19.6%) | $1.24B(+12.5%) |
| Sep 2023 | - | $331.82M(+27.0%) | $1.10B(+10.1%) |
| Jun 2023 | - | $261.24M(+3.1%) | $1.00B(+2.8%) |
| Mar 2023 | - | $253.50M(-1.9%) | $975.68M(+4.6%) |
| Dec 2022 | $933.01M(+32.9%) | $258.43M(+12.2%) | $933.01M(+6.5%) |
| Sep 2022 | - | $230.27M(-1.4%) | $876.05M(+4.9%) |
| Jun 2022 | - | $233.49M(+10.7%) | $835.18M(+9.1%) |
| Mar 2022 | - | $210.83M(+4.7%) | $765.79M(+9.1%) |
| Dec 2021 | $701.89M(+30.0%) | $201.46M(+6.4%) | $701.89M(+8.7%) |
| Sep 2021 | - | $189.41M(+15.4%) | $645.56M(+7.6%) |
| Jun 2021 | - | $164.09M(+11.7%) | $600.08M(+4.7%) |
| Mar 2021 | - | $146.93M(+1.2%) | $573.36M(+6.2%) |
| Dec 2020 | $540.10M(+41.8%) | $145.14M(+0.8%) | $540.10M(+9.1%) |
| Sep 2020 | - | $143.92M(+4.8%) | $495.07M(+10.0%) |
| Jun 2020 | - | $137.36M(+20.8%) | $450.19M(+10.5%) |
| Mar 2020 | - | $113.67M(+13.5%) | $407.50M(+7.0%) |
| Dec 2019 | $380.83M(+26.5%) | $100.11M(+1.1%) | $380.83M(+4.3%) |
| Sep 2019 | - | $99.04M(+4.6%) | $365.13M(+6.0%) |
| Jun 2019 | - | $94.67M(+8.8%) | $344.58M(+6.5%) |
| Mar 2019 | - | $87.01M(+3.1%) | $323.44M(+7.4%) |
| Dec 2018 | $301.03M(+94.7%) | $84.42M(+7.6%) | $301.03M(+9.9%) |
| Sep 2018 | - | $78.49M(+6.7%) | $273.90M(+13.5%) |
| Jun 2018 | - | $73.53M(+13.8%) | $241.36M(+19.0%) |
| Mar 2018 | - | $64.60M(+12.8%) | $202.85M(+31.2%) |
| Dec 2017 | $154.58M(+2751.6%) | $57.28M(+24.6%) | $154.58M(+50.5%) |
| Sep 2017 | - | $45.95M(+31.3%) | $102.73M(+80.9%) |
| Jun 2017 | - | $35.01M(+114.2%) | $56.77M(+160.9%) |
| Mar 2017 | - | $16.34M(+201.5%) | $21.76M(+301.5%) |
| Dec 2016 | $5.42M(+332.6%) | $5.42M(>+9900.0%) | $5.42M(+332.6%) |
| Sep 2016 | - | $0.00(0.0%) | $1.25M(0.0%) |
| Jun 2016 | - | $0.00(0.0%) | $1.25M(0.0%) |
| Mar 2016 | - | $0.00(-100.0%) | $1.25M(0.0%) |
| Dec 2015 | $1.25M(-87.2%) | $1.25M(>+9900.0%) | $1.25M(+4540.7%) |
| Sep 2015 | - | $0.00(0.0%) | $27.00K(-97.5%) |
| Jun 2015 | - | $0.00(0.0%) | $1.09M(-70.4%) |
| Mar 2015 | - | $0.00(-100.0%) | $3.67M(-62.4%) |
| Dec 2014 | $9.76M(-31.4%) | $27.00K(-97.5%) | $9.76M(-21.0%) |
| Sep 2014 | - | $1.06M(-59.0%) | $12.36M(-20.1%) |
| Jun 2014 | - | $2.58M(-57.6%) | $15.46M(-2.3%) |
| Mar 2014 | - | $6.09M(+131.8%) | $15.83M(+11.4%) |
| Dec 2013 | $14.22M(-61.9%) | $2.63M(-37.0%) | $14.22M(-24.9%) |
| Sep 2013 | - | $4.17M(+41.2%) | $18.93M(-15.2%) |
| Jun 2013 | - | $2.95M(-34.0%) | $22.34M(-27.0%) |
| Mar 2013 | - | $4.47M(-39.0%) | $30.59M(-18.1%) |
| Dec 2012 | $37.33M(-20.6%) | $7.34M(-3.1%) | $37.33M(-14.3%) |
| Sep 2012 | - | $7.57M(-32.4%) | $43.58M(+0.1%) |
| Jun 2012 | - | $11.21M(-0.0%) | $43.53M(-0.9%) |
| Mar 2012 | - | $11.21M(-17.5%) | $43.91M(-6.6%) |
| Dec 2011 | $46.99M | $13.59M(+80.6%) | $46.99M(-3.9%) |
| Sep 2011 | - | $7.52M(-35.1%) | $48.92M(-2.4%) |
| Jun 2011 | - | $11.59M(-19.0%) | $50.10M(+17.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | $14.30M(-7.9%) | $42.51M(+44.5%) |
| Dec 2010 | $29.42M(+67.3%) | $15.52M(+78.3%) | $29.42M(+54.5%) |
| Sep 2010 | - | $8.70M(+117.7%) | $19.05M(+14.1%) |
| Jun 2010 | - | $4.00M(+231.7%) | $16.69M(+6.7%) |
| Mar 2010 | - | $1.21M(-76.6%) | $15.64M(-11.1%) |
| Dec 2009 | $17.59M(-17.3%) | $5.14M(-19.0%) | $17.59M(-1.9%) |
| Sep 2009 | - | $6.35M(+115.6%) | $17.92M(+8.2%) |
| Jun 2009 | - | $2.94M(-6.5%) | $16.56M(-11.0%) |
| Mar 2009 | - | $3.15M(-42.5%) | $18.60M(-11.7%) |
| Dec 2008 | $21.26M(+93.5%) | $5.48M(+10.0%) | $21.07M(+1.4%) |
| Sep 2008 | - | $4.98M(0.0%) | $20.78M(+11.1%) |
| Jun 2008 | - | $4.98M(-11.4%) | $18.71M(+16.4%) |
| Mar 2008 | - | $5.62M(+8.5%) | $16.07M(+46.3%) |
| Dec 2007 | $10.99M(+9427.5%) | $5.19M(+78.1%) | $10.99M(+88.9%) |
| Sep 2007 | - | $2.91M(+23.8%) | $5.82M(+99.3%) |
| Jun 2007 | - | $2.35M(+338.7%) | $2.92M(+398.5%) |
| Mar 2007 | - | $536.00K(+2962.9%) | $585.40K(+407.3%) |
| Dec 2006 | $115.30K(-97.6%) | $17.50K(+31.6%) | $115.40K(-92.4%) |
| Sep 2006 | - | $13.30K(-28.5%) | $1.52M(-68.3%) |
| Jun 2006 | - | $18.60K(-71.8%) | $4.78M(-0.4%) |
| Mar 2006 | - | $66.00K(-95.3%) | $4.80M(+0.4%) |
| Dec 2005 | $4.78M(+1011.2%) | $1.42M(-56.8%) | $4.78M(+31.0%) |
| Sep 2005 | - | $3.28M(+8250.6%) | $3.65M(+862.8%) |
| Jun 2005 | - | $39.30K(-13.1%) | $379.30K(+0.8%) |
| Mar 2005 | - | $45.20K(-84.2%) | $376.30K(-12.6%) |
| Dec 2004 | $430.50K(-55.6%) | $285.60K(+3004.3%) | $430.60K(+53.7%) |
| Sep 2004 | - | $9200.00(-74.7%) | $280.20K(-59.1%) |
| Jun 2004 | - | $36.30K(-63.5%) | $685.40K(-15.5%) |
| Mar 2004 | - | $99.50K(-26.4%) | $811.50K(-16.3%) |
| Dec 2003 | $970.00K(+15.9%) | $135.20K(-67.4%) | $969.90K(-3.4%) |
| Sep 2003 | - | $414.40K(+155.2%) | $1.00M(+22.2%) |
| Jun 2003 | - | $162.40K(-37.0%) | $821.50K(-4.2%) |
| Mar 2003 | - | $257.90K(+52.4%) | $857.10K(+2.4%) |
| Dec 2002 | $837.00K(+18.6%) | $169.20K(-27.1%) | $836.90K(-13.1%) |
| Sep 2002 | - | $232.00K(+17.2%) | $963.00K(-7.3%) |
| Jun 2002 | - | $198.00K(-16.7%) | $1.04M(+11.9%) |
| Mar 2002 | - | $237.70K(-19.5%) | $928.30K(+31.4%) |
| Dec 2001 | $706.00K(-45.6%) | $295.30K(-4.1%) | $706.60K(+62.0%) |
| Sep 2001 | - | $308.00K(+252.8%) | $436.30K(+74.2%) |
| Jun 2001 | - | $87.30K(+445.6%) | $250.50K(+38.1%) |
| Mar 2001 | - | $16.00K(-36.0%) | $181.40K(-86.0%) |
| Dec 2000 | $1.30M(+7529.4%) | $25.00K(-79.5%) | $1.30M(+1.2%) |
| Sep 2000 | - | $122.20K(+571.4%) | $1.28M(+10.2%) |
| Jun 2000 | - | $18.20K(-98.4%) | $1.16M(+1.6%) |
| Mar 2000 | - | $1.13M(>+9900.0%) | $1.14M(+6634.1%) |
| Dec 1999 | $17.00K(-85.9%) | $9200.00(+155.6%) | $17.00K(-84.7%) |
| Sep 1999 | - | $3600.00(+3500.0%) | $111.40K(-1.2%) |
| Jun 1999 | - | $100.00(-97.6%) | $112.80K(-5.1%) |
| Mar 1999 | - | $4100.00(-96.0%) | $118.90K(-1.2%) |
| Dec 1998 | $120.40K(+742.0%) | $103.60K(+1972.0%) | $120.40K(+616.7%) |
| Sep 1998 | - | $5000.00(-19.4%) | $16.80K(-85.0%) |
| Jun 1998 | - | $6200.00(+10.7%) | $111.80K(-45.6%) |
| Mar 1998 | - | $5600.00(-94.4%) | $205.60K(-31.5%) |
| Dec 1997 | $14.30K(-85.7%) | - | - |
| Sep 1997 | - | $100.00K(0.0%) | $300.00K(+50.0%) |
| Jun 1997 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Mar 1997 | - | $100.00K | $100.00K |
| Dec 1996 | $100.00K | - | - |
FAQ
- What is Sarepta Therapeutics, Inc. annual revenue?
- What is the all time high annual revenue for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. annual revenue year-on-year change?
- What is Sarepta Therapeutics, Inc. quarterly revenue?
- What is the all time high quarterly revenue for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. quarterly revenue year-on-year change?
- What is Sarepta Therapeutics, Inc. TTM revenue?
- What is the all time high TTM revenue for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. TTM revenue year-on-year change?
What is Sarepta Therapeutics, Inc. annual revenue?
The current annual revenue of SRPT is $1.90B
What is the all time high annual revenue for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high annual revenue is $1.90B
What is Sarepta Therapeutics, Inc. annual revenue year-on-year change?
Over the past year, SRPT annual revenue has changed by +$658.64M (+52.97%)
What is Sarepta Therapeutics, Inc. quarterly revenue?
The current quarterly revenue of SRPT is $611.09M
What is the all time high quarterly revenue for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high quarterly revenue is $744.86M
What is Sarepta Therapeutics, Inc. quarterly revenue year-on-year change?
Over the past year, SRPT quarterly revenue has changed by +$248.16M (+68.38%)
What is Sarepta Therapeutics, Inc. TTM revenue?
The current TTM revenue of SRPT is $2.48B
What is the all time high TTM revenue for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high TTM revenue is $2.48B
What is Sarepta Therapeutics, Inc. TTM revenue year-on-year change?
Over the past year, SRPT TTM revenue has changed by +$976.54M (+64.89%)